Researchers assigned subjects with physician-confirmed osteoarthritis to supplement with 2 g of BioCell Collagen or placebo for 70 days.
Fresh off the success of a human trial on BioCell Collagen and skin health, BioCell Technology LLC (Newport Beach, CA) says its signature ingredient has demonstrated osteoarthritis support in a study on 80 human subjects.
Researchers assigned subjects with physician-confirmed osteoarthritis (in the hip and/or knee joint) to supplement with 2 g of BioCell Collagen or placebo for 70 days. At days 1, 35, and 70, subjects answered Visual Analogue Scale (VAS) and WOMAC pain questionairres.
Compared to placebo, BioCell Collagen supplementation was associated with better VAS and WOMAC scores and significant improvement in physical activities.
The study is now published in the Journal of Agricultural Food and Chemistry.
Glanbia Nutritionals announces launch of high potency collagen tripeptide ingredient
June 4th 2024According to the company, Collamet is absorbed four times faster and has 10 times the efficacy of traditional collagen peptides. The ingredient will initially be offered in the North American market.